secwatch.observer — SEC 8-K summary
======================================

Issuer:     AETHLON MEDICAL INC (AEMD)
CIK:        0000882291
Form:       8-K
Filed at:   2026-01-26T23:59:59+00:00
Accession:  0001683168-26-000528
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aethlon removes shareholder approval condition; pre-funded warrants immediately exercisable
--------------------------------------------------------------------------------

- Amendments to SPA and Pre-Funded Warrant remove Nasdaq 5635 shareholder approval requirement, effective Jan 22, 2026.
- Pre-funded warrants issued to Armistice Capital (institutional investor) are now immediately exercisable.
- No other terms of the original December 2025 agreements were changed.
- Company's common stock trades on Nasdaq under ticker AEMD.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/882291/000168316826000528/0001683168-26-000528-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/882291/000168316826000528/aethlon_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000528

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer